ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645575 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645575; 2) Community: the network communities that were significantly associated with the response to NSC 645575; 3) Molecule: the relationships between components within communities and NSC 645575; 4) MDR: the compounds that were significantly associated with the NSC 645575.

NSC Compound Enrichment Correlation
NSC 674347 4-(1,1-Dimethylethyl)-1-(1-methylethyl)-{9,10-dihydro-12-met hoxy-8-hydroxymethyl-9-oxoindolizo[1,2-b]quinolin-7-yl}butanedioate 0.045446901295916 0.12191787
NSC 675766 Null 0.045446901295916 -0.26423086
NSC 676353 Null 0.045446901295916 0.36558385
NSC 676917 1-[m-Anisidic anilino malonyl]-3-methyl-4-[4'-.beta.-sulphato ethyl sulphonyl phenyl azo]-5-pyrazolone 0.045446901295916 0.31497139
NSC 678403 Null 0.045446901295916 -0.046200346
NSC 681635 Camptothecin Derivative 0.045446901295916 0.12690658
NSC 688978 Perylene-4,9-dione, 5,8-dihydroxy-1,3,10,12-tetramethoxy- 6,7-dipropyl- 0.045446901295916 0.11115494
NSC 691608 Null 0.045446901295916 0.40961017
NSC 702378 Null 0.045446901295916 0.20615089
NSC 704637 Null 0.045446901295916 0.34215517
Total:69  Current:59    [First] [Prev] [Next] [Last]